Image

Cycle and Stroke With Biofeedback for Power Symmetry

Cycle and Stroke With Biofeedback for Power Symmetry

Recruiting
18-70 years
All
Phase N/A

Powered by AI

Overview

To determine changes in power symmetry, gait symmetry, and functional outcomes for participants' poststroke (Inpatient Rehabilitation Facility) after participating in an intervention using a recumbent cycle with power biofeedback (BFB). To determine how this intervention can impact gait asymmetry, a common disorder poststroke secondary to hemiparesis. Gait asymmetry is a difficult impairment to treat because it is difficult for both therapists and patients to perceive. Training with BFB allows for quantitative data about the power production or lack of that directly impacts safety in walking, increased energy expenditure, and decreased gait speed.

Description

Specific Aim 1 will determine the change in cycling power using BFB on a group of participants with stroke in an Inpatient Rehabilitation Facility. Specific Aim 2 will determine the effect size of the change in gait symmetry with cycling training with power BFB pre- to post-cycle intervention. Specific Aim 3 will determine the effect size of the change in functional mobility with cycling training with power BFB pre- to post-cycle intervention. Understanding the impact of cycle training with power BFB is an important step in improving stroke rehabilitation. This study is significant because it will provide data about power asymmetries in participants' early post-acute stroke and the transfer of training with power BFB to gait impairments.

Eligibility

Inclusion Criteria:

  1. they have a confirmed MCA or ACA ischemic or intracerebral hemorrhagic stroke, confirmed by CT/MRI or clinical documentation

    -AND demonstrating lower extremity hemiparesis [< 100 on lower limb Motricity Index24]

  2. 18 to 70 years of age
  3. a Functional Ambulation Category of 2 (Dependent Level II) through 5 (Independent Level surfaces only)
  4. medical clearance to participate

Exclusion Criteria:

  1. contractures that limit lower limb range of motion
  2. cardiovascular, respiratory or metabolic instability, including unstable angina or hypertension above 200/110 at rest
  3. uncontrolled diabetes
  4. severe respiratory disorders that limit exercise
  5. inability to ambulate > 150 feet prior to stroke
  6. prior history of peripheral or central nervous system injury
  7. moderate to severe hemispatial neglect according to the Kessler Foundation Neglect Assessment
  8. major cognitive impairment preventing the capability to understand training instructions; identified by inability to follow 3-step command
  9. severe aphasia preventing communication with the therapist.

Study details
    Stroke

NCT06857916

University of Utah

29 March 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.